Novo Nordisk A/S Sponsored ADR Class B (NVO) is currently at $46.67, up $0.27 or 0.58%
--Would be highest close since Feb. 20, 2026, when it closed at $47.42
--On pace for largest percent increase since May 11, 2026, when it rose 0.72%
--Currently up nine consecutive days; up 15.84% over this period
--Longest winning streak since Dec. 5, 2022, when it rose for nine straight trading days
--Best nine day stretch since the nine days ending Jan. 13, 2026, when it rose 16.44%
--Up 10.54% month-to-date
--Down 8.27% year-to-date
--Down 68.23% from its all-time closing high of $146.91 on June 25, 2024
--Down 28.64% from 52 weeks ago (May 13, 2025), when it closed at $65.40
--Down 42.42% from its 52-week closing high of $81.05 on June 12, 2025
--Up 32.25% from its 52-week closing low of $35.29 on March 30, 2026
--Traded as high as $47.11
--Up 1.53% at today's intraday high
All data as of 10:44:32 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 12, 2026 10:47 ET (14:47 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.